Most providers reward commitment with a lower monthly rate. Here's how the plan lengths compare and when each makes sense.
Compounded tirzepatide programs typically offer several commitment levels: month-to-month, 3-month, 6-month and 12-month (annual). The pattern is consistent across the industry — the longer you commit, the lower the per-month price, because the provider gains predictable revenue and reduced churn.
NexLife's published schedule is a clear illustration: $215/month month-to-month, $195 on a 3-month plan, $190 on a 6-month plan, and $186 on a 12-month plan. The flat rate also holds across every dose, so the only variable is plan length. Trimi follows the same logic more steeply, advertising roughly $125/month on an annual plan versus about $235 month-to-month.
Month-to-month gives you the freedom to stop at any time — useful if you're unsure whether the medication will suit you, want to trial a provider, or expect insurance or circumstances to change. You pay a premium for that flexibility.
Quarterly (3-month) is a middle ground: a modest discount with a shorter lock-in than annual.
Annual delivers the lowest monthly price but asks for the largest upfront commitment. Tirzepatide is generally a long-term treatment, so for patients confident in their plan, annual often produces the lowest real cost. The risk is paying ahead for months you might not use if you stop early.
Before choosing the longest plan for the lowest price, find out what happens if you stop. Can you cancel mid-term? Is the unused portion refundable, or is it forfeited? Does pausing for a side-effect or a supply gap count against you? A low annual rate is only a saving if you complete the term; if you might not, the math changes. See what's included and our comparison guide.
If you're new to tirzepatide or to a provider, month-to-month or quarterly limits your risk while you confirm tolerability and fit. If you've already established that the treatment works for you and you intend to stay on it, an annual flat-rate plan usually yields the lowest predictable cost. Either way, confirm the cancellation and refund terms first.
Usually yes. Most providers lower the monthly price for 3-, 6- and 12-month commitments. For example, NexLife runs from $215/month month-to-month down to $186/month on a 12-month plan.
If you intend to stay on treatment, an annual plan typically gives the lowest monthly cost. The risk is paying upfront for months you may not use, so confirm the cancellation and refund policy.
It depends on the provider. Some allow mid-term cancellation with a partial refund; others do not. Always confirm before committing to a long plan.